tirzepatide approved for teens Microdose GLP-1 Medications Are Becoming More

For researchers considering a taper schedule, the dosage calculator can help plan the exact reconstitution volumes needed at each reduced dose tier

The FDA approved tirzepatide for chronic weight management for adults with obesity or with overweight and one weight-related comorbidity in November

Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide), the newest medication geared specifically toward weight loss

Your provider will start you on a low dose of 2.5 mg weekly to minimize potential side effects and allow your body to adjust

Health Canada has approved 6 medications for long-term obesity management: liraglutide (Saxenda), naltrexonebupropion (Contrave), orlistat (Xenical), semaglutide (Wegovy), tirzepatide (Zepbound), and setmelanotide (Imcivree)